ARTICLE | Clinical News
ACR343: Phase I started
December 24, 2007 8:00 AM UTC
NEUR began a double-blind, placebo-controlled, single-ascending dose, Swedish Phase I trial of oral ACR343 in healthy volunteers. The milestone triggers a SEK75 million payment to former shareholders ...